Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug, Other
  • Participants: 74
  • Start Date: October 1, 2021
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE): A Pilot Randomized Controlled Trial
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 214
  • Start Date: March 2021
A Pregnancy Registry to Evaluate the Safety of Dengue Vaccine Among Inadvertently Exposed Pregnant Women and Their Offsprings (DNG16)
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 8000
  • Start Date: February 15, 2021
Serosurvey for Prevalence and Incidence of Lassa Virus Infection in Southern Mali
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Other
  • Participants: 80
  • Start Date: February 15, 2021
Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-Endemic Participants in Cambodia
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological, Other
  • Participants: 30
  • Start Date: February 2021
A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Rift Valley Fever Virus (RVFV) Vaccine ChAdOx1 RVF Among Healthy Adult Volunteers in Uganda
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Biological
  • Participants: 500
  • Start Date: February 2021
Dengvaxia US Pregnancy Registry: A Surveillance Study to Assess the Safety of Dengvaxia Among Exposed Pregnant Women and Their Offsprings (DNG00044)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 25
  • Start Date: February 1, 2021
An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease Based on Humanized Monoclonal Antibodies
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 10
  • Start Date: February 2021
A Study to Evaluate the Safety and Efficacy of PV-001-DV in Combination With Infusion of PV-001-DC in Patients With Advanced Melanoma
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Combination Product, Biological, Drug
  • Participants: 360
  • Start Date: February 2021
(Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 294
  • Start Date: January 25, 2021
High-Dose Ivermectin for Mild-to-Moderate COVID-19 - The (HD)IVACOV Trial
Showing 1-12 of 91